Should You Buy Cameco While It's Below $90?

Cameco, a leading uranium producer, has rallied 63% YTD and 251% over three years but is trading ~24% below its 52-week high (under $90). The company holds major stakes in McArthur River (70%), Cigar Lake (55%), Key Lake mill (83%) and 40% of Inkai, plus a 49% interest in Westinghouse; a partnership with Brookfield and Westinghouse and U.S. executive actions could support an estimated $80 billion-plus reactor build program. Management cut 2025 McArthur River/Key Lake production to 14–15M lbs U3O8 (Cameco share 9.8–10.5M) from 18M due to development delays, a shortfall analysts call largely immaterial and potentially recovered in 2026; EPS is projected to grow to $2.25 by 2028 (≈30% annual growth from 2025), though the stock currently trades at ~55x this year’s projected earnings.

Analysis

Market structure: Nuclear policy tailwinds and a U.S. strategic uranium reserve sharply improve demand visibility for U3O8 while supply remains lumpy — Cameco’s share of McArthur River/Key Lake was cut to 9.8–10.5M lbs for 2025 vs prior 18M industry guidance, highlighting multi-year supply inelasticity. Winners: integrated, low-cost producers (CCJ), Westinghouse OEM suppliers (49% economic exposure via Brookfield JV) and reactor constructors; losers: marginal high‑cost juniors and spot-only traders. Cross-asset: higher large-scale infrastructure spending tends to steepen yield curves (pressure on long bonds), lift CAD/KZT versus USD on commodity flows, and increase commodity-curve backwardation in uranium, while raising equity vol for cyclical miners.

Risk assessment: Tail risks include a political reversal of U.S. nuclear policy, a significant Kazakhstan operational shock (40% JV Inkai exposure), or major Westinghouse build delays — each could swing CCJ >30% either way within 12–24 months. Near-term (days-weeks): headline risk from US reserve decisions and quarterly production updates; medium (3–12 months): execution at McArthur River and ground-freezing cadence; long (2–5 years): realization of reactor contracts and sustained contract re-pricing to utilities. Hidden dependencies: CCJ’s valuation now embeds accelerated Westinghouse optionality — project execution and Brookfield capital allocation matter materially.

Trade implications: Implement a size-weighted, staged long in CCJ (2–3% portfolio) with 50% entry now and add-to on pullbacks to $70–75 or after proof-of-production recovery to >11M lbs in 2026; cap downside with a 12–18 month $70 protective put. Use a leveraged bullish options structure (Jan‑2027 $90/$140 call spread) to target 2–3x upside with defined cost, and run a relative-value pair: long CCJ vs short uranium junior basket (e.g., URNM) to neutralize sector beta. Rotate 1–1.5% into BEP/BAM to capture Westinghouse upside at lower multiples; reduce cyclical precious-metal/miners exposure by 1–2%.

Contrarian angles: The market is underpricing execution and timeline risk — 55x forward earnings is a premium that assumes smooth Westinghouse monetization and rapid contract wins; history (2007 uranium boom/bust) warns of sharp re-rates if reactor build timelines slip. Mispricing: higher-quality, cash-generative CCJ may trade rich versus Brookfield-linked Westinghouse exposure which could be cheaper to own via BEP/BAM; unintended consequence: U.S. reserve purchasing could remove liquidity from spot market, amplifying spikes but reducing long-term price discovery.

Key Decisions for Investors

• Establish a staged long position in CCJ equal to 2–3% of portfolio NAV: deploy 50% at market (~< $90) and scale remaining 50% on pullbacks to $70–75 or after a confirmed production recovery (Cameco’s 2026 share >11M lbs).
• Hedge the long with a protective 12–18 month put roughly 20–25% OTM (e.g., $70 strike) sized to cover at least 50% of the equity position, or fund upside with a Jan‑2027 $90/$140 call spread to concentrate upside with defined cost.
• Execute a pair trade: long CCJ (notional X) and short junior uranium miners/URNM (notional ~0.5–0.75X) to capture quality premium; trim pair if CCJ/URNM relative outperforms by >30% or if Cameco revises 2026 production down again.
• Allocate 1–1.5% to Brookfield exposure (BEP/BAM) to capture Westinghouse upside at a lower EV/earnings multiple; exit if Brookfield announces inability to fund Westinghouse capex or if CCJ’s Westinghouse-derived NAV revision is removed.
• Trigger-based monitoring (mandatory): exit/reduce CCJ if (a) Cameco lowers 2026 share to <9M lbs, (b) US strategic reserve plan is shelved within 90 days, or (c) CCJ trades above 120 (sell half to realize gains).